Anavex Life Sciences Corp (AVXL)

[McMagyar]

To keep it simple ,,in less than a month..
at the World Parkinson's Conference, a
TEAM of great and good Doctors that work with
the MIchael J. Fox Foundation,
will expand on these statements:
"
). Ongoing experiments on mice sustaining 6-
OHDA lesions show trends towards an amelioration of parkinsonian
motor symptoms in tests assessing spontaneous rotational activity
and forelimb use asymmetry.
Significance:
If successful, this study will accelerate the clinical
development of ANAVEX 2-73 as a potential disease-modifying
therapy for PD. We are in the fortunate situation that safety,
bioavailability, tolerability of this compound have already been
proven in human subjects, and that preliminary indications of a
cognitive benefit have been obtained in a Phase 2a clinical trial for
Alzheimer’s disease (ANAVEX)"